$LXRP ---


BAT has already made vaccines before for Ebola (BAT is currently working with BAT in research studies).

https://www.bat.com/group/sites/UK__9D9KCY.ns...e/DOBN8QNL

The vaccine in development uses BAT’s proprietary, fast-growing tobacco plant technology which has several advantages over conventional vaccine production technology:

"It is potentially safer given that tobacco plants can’t host pathogens which cause human disease.

It is faster because the elements of the vaccine accumulate in tobacco plants much more quickly – 6 weeks in tobacco plants versus several months using conventional methods.

The vaccine formulation KBP is developing remains stable at room temperature, unlike conventional vaccines which often require refrigeration.

It has the potential to deliver an effective immune response in a single dose.

BAT’s US subsidiary, Reynolds American Inc, acquired KBP in 2014, with the aim of using some of its unique tobacco extraction technology to aid further development of its new category non-combustible products.

In 2014, KBP made headlines as one of the few companies with an effective treatment for Ebola, having manufactured ZMapp™ with California-based company Mapp BioPharmaceuticals in partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA)".

An oral vaccine would be far more user friendly than an injection. You wouldn't necessarily need doctors to administer the pills like you would with inoculations. Perhaps people could just head to the post office to pick up their dose. Also, a lot of folks don't like needles --- something health professionals should think about.

Since BAT has already produced vaccines, the use of a pill or capsule to administer vaccines would help BAT to have a great inject-able version as well as an oral one!

BAT could be a great partner for Lexaria. They are obviously diversifying big time and Lexaria would be perfect for all sorts of their new ventures. Oral nicotine and oral vaccines could have a huge potential just for starters. What else could we do with them? It boggles the mind.


Kgem